{"id":"https://openalex.org/W2188239458","doi":null,"title":"Predictive criteria of sustained virological response (more than 60 months) to Nevirapine-based antiretroviral treatment","display_name":"Predictive criteria of sustained virological response (more than 60 months) to Nevirapine-based antiretroviral treatment","publication_year":2011,"publication_date":"2011-01-01","ids":{"openalex":"https://openalex.org/W2188239458","mag":"2188239458"},"language":"en","primary_location":{"id":"mag:2188239458","doi":null,"is_oa":false,"landing_page_url":"http://win.mnlpublimed.com/public/HA12-A07.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null},"volume":null,"type":"article","indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5041785868","display_name":"Benedetto Maurizio Celesia","orcid":"https://orcid.org/0000-0002-6919-1955","observed_orcids":["https://orcid.org/0000-0002-6919-1955"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Benedetto Maurizio Celesia","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-6919-1955","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063644641","display_name":"Francesco Bellissimo","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Francesco Bellissimo","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023836634","display_name":"Marilia Rita Pinzone","orcid":"https://orcid.org/0000-0001-6764-567X","observed_orcids":["https://orcid.org/0000-0001-6764-567X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Marilia Rita Pinzone","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088922224","display_name":"Luciano Nigro","orcid":"https://orcid.org/0009-0004-1219-9608","observed_orcids":["https://orcid.org/0009-0004-1219-9608"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Luciano Nigro","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0004-1219-9608","affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Raymond Rosa","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Raymond Rosa","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088785962","display_name":"Christian Coco","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"C. Coco","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071969713","display_name":"Maria Gussio","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Maria Gussio","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"P Nicotra","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"P Nicotra","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091439508","display_name":"Filippo Palermo","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Filippo Palermo","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033992081","display_name":"Sebastiano Cosentino","orcid":"https://orcid.org/0000-0002-9404-843X","observed_orcids":["https://orcid.org/0000-0002-9404-843X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sebastiano Cosentino","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5058992754","display_name":"Giuseppe Nunnari","orcid":"https://orcid.org/0000-0002-8113-8452","observed_orcids":["https://orcid.org/0000-0002-8113-8452"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Giuseppe Nunnari","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-8113-8452","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.17724844,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.9887999892234802,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.9887999892234802,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10082","display_name":"HIV/AIDS Research and Interventions","score":0.006599999964237213,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10112","display_name":"HIV Research and Treatment","score":0.002400000113993883,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/nevirapine","display_name":"nevirapine","score":0.9990000128746033},{"id":"https://openalex.org/keywords/hiv-infection","display_name":"HIV infection","score":0.7710000276565552},{"id":"https://openalex.org/keywords/non-nucleoside-reverse-transcriptase-inhibitors","display_name":"non-nucleoside reverse transcriptase inhibitors","score":0.9120000004768372},{"id":"https://openalex.org/keywords/sustained-virologic-response","display_name":"sustained virological response","score":0.9649999737739563},{"id":"https://openalex.org/keywords/predictive-factors","display_name":"predictive factors","score":0.7239999771118164},{"id":"https://openalex.org/keywords/antiretroviral-therapy","display_name":"antiretroviral therapy","score":0.7960000038146973},{"id":"https://openalex.org/keywords/treatment-failure","display_name":"treatment failure","score":0.593999981880188},{"id":"https://openalex.org/keywords/hepatitis-c-coinfection","display_name":"hepatitis C coinfection","score":0.7879999876022339},{"id":"https://openalex.org/keywords/hepatotoxicity","display_name":"hepatotoxicity","score":0.8130000233650208},{"id":"https://openalex.org/keywords/drug-hypersensitivity","display_name":"drug hypersensitivity","score":0.6380000114440918}],"concepts":[{"id":"https://openalex.org/C2779130552","wikidata":"https://www.wikidata.org/wiki/Q263713","display_name":"Nevirapine","level":5,"score":0.9617122411727905},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.733348548412323},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.6732749342918396},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6027776598930359},{"id":"https://openalex.org/C2777351918","wikidata":"https://www.wikidata.org/wiki/Q421559","display_name":"Reverse-transcriptase inhibitor","level":5,"score":0.570701003074646},{"id":"https://openalex.org/C3019165603","wikidata":"https://www.wikidata.org/wiki/Q583050","display_name":"Antiretroviral treatment","level":5,"score":0.47405001521110535},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.4727673828601837},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.4673704504966736},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.45676493644714355},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.4340501129627228},{"id":"https://openalex.org/C142462285","wikidata":"https://www.wikidata.org/wiki/Q2528140","display_name":"Viral load","level":3,"score":0.39848804473876953},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3491848111152649},{"id":"https://openalex.org/C2993143319","wikidata":"https://www.wikidata.org/wiki/Q583050","display_name":"Antiretroviral therapy","level":4,"score":0.28997039794921875}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2188239458","doi":null,"is_oa":false,"landing_page_url":"http://win.mnlpublimed.com/public/HA12-A07.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":17,"referenced_works":["https://openalex.org/W1964314707","https://openalex.org/W1968262541","https://openalex.org/W1997408197","https://openalex.org/W2032619697","https://openalex.org/W2057394385","https://openalex.org/W2062515126","https://openalex.org/W2064157685","https://openalex.org/W2064590924","https://openalex.org/W2085066934","https://openalex.org/W2135594909","https://openalex.org/W2136097824","https://openalex.org/W2137230427","https://openalex.org/W2137262613","https://openalex.org/W2167040690","https://openalex.org/W2167865974","https://openalex.org/W2221088623","https://openalex.org/W2411579330"],"related_works":["https://openalex.org/W2061632791","https://openalex.org/W1986554823","https://openalex.org/W2167592529","https://openalex.org/W2025994307","https://openalex.org/W6927559816","https://openalex.org/W3008202357","https://openalex.org/W2025351576","https://openalex.org/W7100378565","https://openalex.org/W1481737560","https://openalex.org/W2082906301"],"abstract_inverted_index":{"Background":[0],"Nevirapine":[1],"(NVP)":[2],"was":[3],"the":[4,15,38],"first":[5],"non-nucleoside":[6],"reverse":[7],"transcriptase":[8],"inhibitor":[9],"(NNRTI)":[10],"to":[11,61],"be":[12],"used":[13],"for":[14,51,65,100,124],"treatment":[16,125],"of":[17,44,57,78,87,104,114],"HIV":[18,89,105],"infection.":[19],"NVP":[20,68],"is":[21,60],"generally":[22],"a":[23,47,52,76,94],"well":[24],"tollerated":[25],"drug;":[26],"early":[27],"adverse":[28],"events,":[29],"such":[30],"as":[31],"hypersensitive":[32],"reactions":[33],"and":[34,83,119],"hepatic":[35,118],"toxicity,":[36],"are":[37],"main":[39],"limitations.":[40],"A":[41],"considerable":[42],"number":[43],"patients":[45],"obtain":[46],"durable":[48],"virological":[49,69],"success":[50],"long":[53,66],"time.":[54],"The":[55],"aim":[56],"this":[58],"study":[59],"identify":[62],"predictive":[63],"criteria":[64],"term":[67],"response":[70],"(more":[71],"than":[72],"60":[73],"months)":[74],"in":[75],"cohort":[77],"NNRTIs":[79],"naive":[80],"subjects.":[81],"Patients":[82],"methods":[84],"Clinical":[85],"records":[86],"137":[88],"positive":[90],"subjects":[91],"treated":[92],"with":[93],"NVP-including":[95],"regimen":[96],"were":[97],"retrospectively":[98],"reviewed":[99],"age,":[101],"sex,":[102],"route":[103],"transmission,":[106],"clinical":[107],"stage,":[108],"HCV":[109],"co-infection,":[110],"therapeutic":[111],"regimens,":[112],"length":[113],"treatment,":[115],"side":[116],"effects,":[117],"metabolic":[120],"blood":[121],"values,":[122],"reasons":[123],"failure.":[126]},"counts_by_year":[],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2016-06-24T00:00:00"}